Fortunately, the Veterans Affairs paper isnt the only cohort analysis that testifies to the broad benefits of these drugs
Figure 1 The present review aims to elucidate and describe the molecular mechanisms of the GLP-1RA drugs, semaglutide and liraglutide, and their effectiveness and potential as a therapeutic option against obesity
This suggests that who you treat mattersyour BMI and metabolic profile may influence whether GLP-1s help with drinking
For instance, the American Diabetes Association only recommends the use of GLP-1 drugs for weight loss for those with a body mass index, or BMI, of at least 30, or among those with a BMI of 27 or greater if they have at least one other condition such as type 2 diabetes, hypertension or high cholesterol
Participants were randomized to either continue the medication or switch to a placebo for another 52 weeks
(No, you cant just start with the highest possible dose off the bat, since that may worsen its side effects, according to Kushner.) What to consider before going on a GLP-1 weight-loss medication As long as you meet the medical criteria, which is having a BMI above 30 or having a BMI of 27 as well as a weight-related health condition like high blood pressure, you can be a candidate for a GLP-1 like Wegovy
